Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach

Neoadjuvant intravenous chemotherapy in patients with pseudomyxoma peritonei (PMP) has not shown convincing results. The effectiveness of neoadjuvant intraperitoneal (IP) chemotherapy has never been reported. This prospective, non-randomized phase II study included patients with PMP treated between...

Descripción completa

Detalles Bibliográficos
Autores principales: Prabhu, Aruna, Brandl, Andreas, Wakama, Satoshi, Sako, Shouzou, Ishibashi, Haruaki, Mizumoto, Akiyoshi, Takao, Nobuyuki, Noguchi, Kousuke, Motoi, Shunsuke, Ichinose, Masumi, Liu, Yang, Yonemura, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465601/
https://www.ncbi.nlm.nih.gov/pubmed/32784670
http://dx.doi.org/10.3390/cancers12082212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465601/
https://www.ncbi.nlm.nih.gov/pubmed/32784670
http://dx.doi.org/10.3390/cancers12082212

Ejemplares similares